Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.

Bosma AL, Spuls PI, Garcia-Doval I, Naldi L, Prieto-Merino D, Tesch F, Apfelbacher CJ, Arents BWM, Barbarot S, Baselga E, Deleuran M, Eichenfield LF, Gerbens LAA, Irvine AD, Manca A, Mendes-Bastos P, Middelkamp-Hup MA, Roberts A, Seneschal J, Svensson Å, Thyssen JP, Torres T, Vermeulen FM, Vestergaard C, von Kobyletzki LB, Wall D, Weidinger S, Schmitt J, Flohr C.

Br J Dermatol. 2019 Aug 24. doi: 10.1111/bjd.18452. [Epub ahead of print]

PMID:
31444799
2.

The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm registry: a prospective cohort study.

Sahuquillo-Torralba A, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Acosta E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Rodriguez L, Vilar J, García-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, López-Estebaranz JL, Pujol-Marco C, Descalzo MA, García-Doval I; Biobadaderm Study Group.

J Am Acad Dermatol. 2019 Jul 12. pii: S0190-9622(19)32388-6. doi: 10.1016/j.jaad.2019.07.028. [Epub ahead of print] No abstract available.

PMID:
31306726
3.

Matching burden of skin diseases, demand for dermatological consultations and clinical research activity: results from three national studies.

Gutiérrez-González E, Descalzo-Gallego MA, Molina-Leyva A, Kueder-Pajares T, Buendía-Eisman A, García-Doval I.

Br J Dermatol. 2019 Jul 13. doi: 10.1111/bjd.18337. [Epub ahead of print]

PMID:
31301228
4.

Effectiveness of classic drugs in psoriasis: still alive.

Garcia-Doval I, Sbidian E.

Br J Dermatol. 2019 Aug;181(2):237. doi: 10.1111/bjd.17876. Epub 2019 Jun 28. No abstract available.

PMID:
31250919
5.

Proportion of Potentially Avoidable Referrals From Primary Care to Dermatologists for Cystic Lesions or Benign Neoplasms in Spain: Analysis of Data From the DIADERM Study.

González-Cruz C, Descalzo MÁ, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I, García-Patos V.

Actas Dermosifiliogr. 2019 May 29. pii: S0001-7310(19)30094-8. doi: 10.1016/j.ad.2019.02.003. [Epub ahead of print] English, Spanish.

PMID:
31153547
6.

Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population.

Gonzalez-Cantero A, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Ceballos E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Sahuquillo-Torralba A, Rodriguez L, Vilar J, García C, Carrascosa JM, Llamas-Velasco M, Herrera-Acosta E, López-Estebaranz JL, Botella-Estrada R, Descalzo MA, García-Doval I; BIOBADADERM Study Group.

Br J Dermatol. 2019 May 25. doi: 10.1111/bjd.18164. [Epub ahead of print] No abstract available.

PMID:
31127858
7.

Do Dermatologic Diagnosis Change in Hot vs. Cold Periods of The Year? A Sub-Analysis of the DIADERM National Sample (Spain 2016).

Gonzalez-Cantero A, Arias-Santiago S, Buendía-Eisman A, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Descalzo MA, García-Doval I.

Actas Dermosifiliogr. 2019 Apr 11. pii: S0001-7310(19)30098-5. doi: 10.1016/j.ad.2019.02.004. [Epub ahead of print] English, Spanish.

PMID:
30982569
8.

Complications and Sequelae After Sentinel Lymph Node Biopsy in Melanoma: A Retrospective Cohort Study.

Espinosa-Pereiro CE, Zulaica Gárate A, García-Doval I.

Actas Dermosifiliogr. 2019 Jul - Aug;110(6):482-489. doi: 10.1016/j.ad.2019.01.003. Epub 2019 Apr 11. English, Spanish.

PMID:
30982568
9.

Diagnosis and Treatment of Merkel Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline of the Spanish Academy of Dermatology and Venereology.

Vázquez Doval J, Llombart Cussac B, Pérez Bustillo A, Paradela de la Morena S, Fuente González MJ, Fernández Figueras MT, Villanueva MJ, Rodríguez Salas N, Descalzo-Gallego MÁ, García-Doval I, Ríos-Buceta L.

Actas Dermosifiliogr. 2019 Jul - Aug;110(6):460-468. doi: 10.1016/j.ad.2019.01.006. Epub 2019 Apr 5. English, Spanish.

PMID:
30961887
10.

Who likes to perform the Psoriasis Area and Severity Index?

Garcia-Doval I, Albrecht J.

Br J Dermatol. 2019 Feb;180(2):260-261. doi: 10.1111/bjd.17441. No abstract available.

PMID:
30714111
11.

How real are 'real-life studies' in psoriasis, and the uncertain meaning of drug persistence.

Garcia-Doval I, Dávila-Seijo P.

Br J Dermatol. 2019 Jan;180(1):15-16. doi: 10.1111/bjd.17104. No abstract available.

PMID:
30604556
12.

Referral of Patients to Dermatology and Teledermatology Consultations in Spain. DIADERM Study.

González-López G, Descalzo-Gallego MÁ, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-El Ahmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, García-Doval I, Buendía-Eisman A; Coordinadores de las secciones; Participantes.

Actas Dermosifiliogr. 2019 Mar;110(2):146-152. doi: 10.1016/j.ad.2018.09.004. Epub 2018 Dec 21. English, Spanish.

PMID:
30583856
13.

Survey on Private Dermatology Practice Characteristics and Fees in Spain in 2018.

Martin-Gorgojo A, García-Doval I, Del Río de la Torre E.

Actas Dermosifiliogr. 2019 Mar;110(2):137-145. doi: 10.1016/j.ad.2018.09.005. Epub 2018 Oct 12. English, Spanish.

PMID:
30322640
14.

Essentials for a successful registry: valid data, the right questions and timely execution.

Garcia-Doval I, Stern RS.

Br J Dermatol. 2018 Oct;179(4):805-806. doi: 10.1111/bjd.16987. No abstract available.

PMID:
30318796
15.

Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study.

Montes-Torres A, Aparicio G, Rivera R, Vilarrasa E, Marcellán M, Notario J, Soria C, Belinchón I, de la Cueva P, Ferrán M, Carrascosa JM, Gómez FJ, Salgado L, Velasco M, Descalzo MÁ, García-Doval I, Daudén E; ; the BIOBADADERM Study Group and Psoriasis Group of the AEDV.

J Dermatolog Treat. 2019 Aug;30(5):461-465. doi: 10.1080/09546634.2018.1535690. Epub 2018 Nov 28.

PMID:
30307344
16.

Difficulties Coding Dermatological Disorders Using the ICD-10: The DIADERM Study.

González-López G, García-Doval I, Molina-Leyva A, Descalzo-Gallego MA, Taberner R, Gilaberte Y, Buendía-Eisman A, Fernández-Peñas P.

Actas Dermosifiliogr. 2018 Dec;109(10):893-899. doi: 10.1016/j.ad.2018.06.006. Epub 2018 Sep 27. English, Spanish.

PMID:
30268517
17.

Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma.

Delgado Jiménez Y, Camarero-Mulas C, Sanmartín-Jiménez O, Garcés JR, Rodríguez-Prieto MÃ, Alonso-Alonso T, Miñano Medrano R, López-Estebaranz JL, de Eusebio Murillo E, Redondo P, Ciudad-Blanco C, Toll A, Artola Igarza JL, Allende Markixana I, Suarez Fernández R, Alfaro Rubio A, Alonso Pacheco ML, Vázquez-Veiga H, de la Cueva Dobao P, Ruiz-Salas V, Vilarrasa E, Barchino L, Morales-Gordillo V, Ocerin-Guerra I, Navarro Tejedor R, Hueso L, Mayor Arenal M, Seoane-Pose MJ, Cano-Martinez N, Garcia-Doval I, Descalzo MA; REGESMOHS.

Int J Dermatol. 2018 Nov;57(11):1375-1381. doi: 10.1111/ijd.14223. Epub 2018 Sep 23.

PMID:
30246444
18.

Evaluation of Structure Indicators for Assessing Skin Cancer Quality of Care in Dermatology Departments.

Kueder-Pajares T, Descalzo MA, García-Doval I, Ríos-Buceta L, Moreno-Ramírez D.

Actas Dermosifiliogr. 2018 Nov;109(9):807-812. doi: 10.1016/j.ad.2018.06.004. Epub 2018 Aug 6. English, Spanish.

PMID:
30093072
19.

Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016.

Carretero Hernández G, Ferrándiz C, Rivera Díaz R, Daudén Tello E, de la Cueva-Dobao P, Gómez-García FJ, Herrera-Ceballos E, Belinchón Romero I, López-Estebaranz JL, Alsina Gibert M, Sánchez-Carazo JL, Ferrán Farrés M, González Quesada A, Carrascosa Carrillo JM, Llamas-Velasco M, Mendiola Fernández MV, Ruiz Genao D, Muñoz Santos C, García-Doval I, Descalzo MA; grupo de estudio de Biobadaderm.

Actas Dermosifiliogr. 2018 Sep;109(7):617-623. doi: 10.1016/j.ad.2018.04.004. Epub 2018 Jun 7. English, Spanish.

PMID:
29887167
20.

Teledermatology Implementation: The Importance of a Clear Objective.

García-Doval I.

Actas Dermosifiliogr. 2018 Sep;109(7):580. doi: 10.1016/j.ad.2018.04.002. Epub 2018 May 25. English, Spanish. No abstract available.

PMID:
29807619
21.

Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland.

Garcia-Doval I, Descalzo MA, Mason KJ, Cohen AD, Ormerod AD, Gómez-García FJ, Cazzaniga S, Feldhamer I, Ali H, Herrera-Acosta E, Griffiths CEM, Stern RS, Naldi L; Psonet Network.

Br J Dermatol. 2018 Oct;179(4):863-871. doi: 10.1111/bjd.16715. Epub 2018 Jul 24.

PMID:
29723914
22.

Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma.

Tejera-Vaquerizo A, García-Doval I, Llombart B, Cañueto J, Martorell-Calatayud A, Descalzo-Gallego MA, Sanmartín O.

J Dermatol. 2018 Jul;45(7):781-790. doi: 10.1111/1346-8138.14342. Epub 2018 Apr 27. Review.

PMID:
29701281
23.

The First Year of the AEVD Primary Cutaneous Lymphoma Registry.

Peñate Y, Servitje O, Machan S, Fernández-de-Misa R, Estrach MT, Acebo E, Mitxelena J, Ramón MD, Flórez A, Blanes M, Morillo M, Medina S, Bassas J, Zayas A, Espinosa P, Pérez A, Gónzalez-Romero N, Domínguez JD, Muniesa C, López Robles J, Combalia A, Yanguas I, Suh H, Polo-Rodríguez I, Bielsa I, Mateu A, Ferrer B, Descalzo MA, García-Doval I, Ortiz-Romero PL.

Actas Dermosifiliogr. 2018 Sep;109(7):610-616. doi: 10.1016/j.ad.2018.03.006. Epub 2018 Apr 19. English, Spanish.

PMID:
29680323
24.

Outpatient Dermatological Diagnoses in Spain: Results From the National DIADERM Random Sampling Project.

Buendía-Eisman A, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Descalzo MÁ, García-Doval I.

Actas Dermosifiliogr. 2018 Jun;109(5):416-423. doi: 10.1016/j.ad.2018.02.003. Epub 2018 Mar 20. English, Spanish.

PMID:
29571521
25.

Clinical research in Dermatology: resources and activities associated with a higher scientific productivity.

Molina-Leyva A, Descalzo MA, García-Doval I.

G Ital Dermatol Venereol. 2019 Aug;154(4):386-391. doi: 10.23736/S0392-0488.18.05864-9. Epub 2018 Mar 6.

26.

Influence of Article Type on the Impact Factor of Dermatology Journals.

Rodríguez-Lago L, Molina-Leyva A, Pereiro-Ferreirós M, García-Doval I.

Actas Dermosifiliogr. 2018 Jun;109(5):432-438. doi: 10.1016/j.ad.2018.01.003. Epub 2018 Feb 26. English, Spanish.

PMID:
29496199
27.

Optimizing case reports and case series: guidance on how to improve quality.

García-Doval I, Albrecht J, Flohr C, Batchelor J, Ingram JR; European Dermato-Epidemiology Network (EDEN).

Br J Dermatol. 2018 Jun;178(6):1257-1262. doi: 10.1111/bjd.16467. Epub 2018 Apr 24. Review.

PMID:
29451697
28.

Description of patients excluded for Mohs surgery after pre-surgical evaluation: data from the Regesmohs Spanish registry.

Ruiz-Salas V, Garcés JR, Alonso-Alonso T, Rodríguez-Prieto MA, Toll-Abelló A, Eusebio Murillo E, Miñano R, López-Estebaranz JL, Sanmartín-Jiménez O, Guillén Barona C, Allende Markixana I, Alfaro Rubio A, Delgado Jiménez Y, Navarro R, Barchino Ortiz L, Lázaro Ochaita P, Vilarasa E, Ciudad Blanco C, Vázquez-Veiga H, Artola Igarza JL, Alonso ML, García-Doval I, Descalzo MA, Redondo Bellón P.

Actas Dermosifiliogr. 2018 May;109(4):346-350. doi: 10.1016/j.ad.2017.11.008. Epub 2018 Jan 17. English, Spanish.

PMID:
29373111
29.

Big data in small diseases: the case of necrotizing soft-tissue infections.

Garcia-Doval I, Nijsten T.

Br J Dermatol. 2017 Dec;177(6):1468-1469. doi: 10.1111/bjd.16025. No abstract available.

PMID:
29313940
30.

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Sbidian E, Chaimani A, Garcia-Doval I, Do G, Hua C, Mazaud C, Droitcourt C, Hughes C, Ingram JR, Naldi L, Chosidow O, Le Cleach L.

Cochrane Database Syst Rev. 2017 Dec 22;12:CD011535. doi: 10.1002/14651858.CD011535.pub2. Review.

31.

Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study.

Descalzo MA, Carretero G, Ferrándiz C, Rivera R, Daudén E, Gómez-García FJ, de la Cueva P, Herrera-Ceballos E, Belinchón I, López-Estebaranz JL, Alsina M, Sánchez-Carazo JL, Ferrán M, Baniandrés O, Carrascosa JM, Llamas-Velasco M, Ruiz-Genao D, Herrera-Acosta E, Muñoz-Santos C, García-Doval I; Biobadaderm Study Group.

J Am Acad Dermatol. 2018 Apr;78(4):798-800. doi: 10.1016/j.jaad.2017.10.051. Epub 2017 Nov 13. No abstract available.

PMID:
29146129
32.

Clinical Research in Dermatology and Venereology in Spanish Research Centers in 2005 Through 2014: Results of the MaIND Study.

Molina-Leyva A, Descalzo MA, García-Doval I.

Actas Dermosifiliogr. 2018 Jan - Feb;109(1):52-57. doi: 10.1016/j.ad.2017.07.008. Epub 2017 Oct 20. English, Spanish.

PMID:
29061291
33.

Systematic reviews: let's keep them trustworthy.

Garcia-Doval I, van Zuuren EJ, Bath-Hextall F, Ingram JR.

Br J Dermatol. 2017 Oct;177(4):888-889. doi: 10.1111/bjd.15826. No abstract available.

PMID:
29052884
34.

Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.

Mercader-García P, Pastor-Nieto MA, García-Doval I, Giménez-Arnau A, González-Pérez R, Fernández-Redondo V, Serra-Baldrich E, Cordoba-Guijarro S, Gatica-Ortega ME, Silvestre-Salvador JF; GEIDAC¶.

Contact Dermatitis. 2018 Jan;78(1):76-82. doi: 10.1111/cod.12874. Epub 2017 Sep 27.

PMID:
28960334
35.

Report from the first European Dermato-Epidemiology Network forum.

Ascott A, Langan SM, García-Doval I, Descalzo MA, Schmidt SAJ, Nijsten T, Hollestein LM.

Br J Dermatol. 2017 Oct;177(4):e168-e171. doi: 10.1111/bjd.15874. Epub 2017 Sep 17.

PMID:
28921488
36.

Mohs micrographic surgery in the elderly: comparison of tumours, surgery and first-year follow-up in patients younger and older than 80 years old in REGESMOHS.

Camarero-Mulas C, Delgado Jiménez Y, Sanmartín-Jiménez O, Garcés JR, Rodríguez-Prieto MA, Alonso-Alonso T, Miñano Medrano R, López-Estebaranz JL, de Eusebio Murillo E, Redondo P, Ciudad-Blanco C, Toll-Abelló A, Artola Igarza JL, Allende Markixana I, Suarez Fernández R, Alfaro Rubio A, Alonso Pacheco ML, Vázquez-Veiga H, de la Cueva Dobao P, Ruiz-Salas V, Vilarrasa Rull E, Barchino L, Morales-Gordillo V, Ocerin-Guerra I, Navarro Tejedor R, Hueso L, Mayor Arenal M, Seoane-Pose MJ, Cano-Martinez N, Garcia-Doval I, Descalzo MA; REGESMOHS (Registro Español de Cirugía de Mohs).

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):108-112. doi: 10.1111/jdv.14586. Epub 2017 Oct 5.

PMID:
28898467
37.

Study of Cognitive Function in Children Treated with Propranolol for Infantile Hemangioma.

González-Llorente N, Del Olmo-Benito I, Muñoz-Ollero N, Descalzo MA, García-Doval I, Torrelo A.

Pediatr Dermatol. 2017 Sep;34(5):554-558. doi: 10.1111/pde.13229. Epub 2017 Aug 14.

PMID:
28804922
38.

Characterization of Surgical Procedures in the Spanish Mohs Surgery Registry (REGESMOHS) for 2013-2015.

de Eusebio Murillo E, Martín Fuentes A, Ruiz-Salas V, Garcés JR, Miñano Medrano R, López-Estebaranz JL, Alonso-Alonso T, Rodríguez-Prieto MÁ, Delgado Jiménez Y, Morales V, Redondo Bellón P, Manubens-Mercadé E, Sanmartín-Jiménez O, Guillén Barona C, Cabeza R, Cano N, Toll-Abelló A, Navarro Tejedor R, Artola Igarza JL, Allende Markixana I, Alfaro Rubio A, Ciudad Blanco C, Vázquez-Veiga H, Barchino Ortiz L, Descalzo MA, García-Doval I.

Actas Dermosifiliogr. 2017 Nov;108(9):836-843. doi: 10.1016/j.ad.2017.04.018. Epub 2017 Aug 9. English, Spanish.

PMID:
28802488
39.

A Map of Clinical Dermatology Research Centers in Spain: Results of the MaIND Study.

Molina-Leyva A, Descalzo MA, García-Doval I.

Actas Dermosifiliogr. 2017 Nov;108(9):830-835. doi: 10.1016/j.ad.2017.05.006. Epub 2017 Jun 29. English, Spanish.

PMID:
28669411
40.

Response to the Comment by Van den Reek et al. on Drug Survival Analysis is not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis.

Dávila-Seijo P, García-Doval I.

Actas Dermosifiliogr. 2017 Sep;108(7):697-698. doi: 10.1016/j.ad.2017.03.011. Epub 2017 May 12. English, Spanish. No abstract available.

PMID:
28504087
41.

Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.

Belinchón I, Ramos JM, Carretero G, Ferrándiz C, Rivera R, Daudén E, De la Cueva-Dobao P, Gómez-García FJ, Herrera-Ceballos E, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Llamas-Velasco M, Ortiz PL, García-Doval I, Descalzo MA; Biobadaderm Study Group.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1700-1708. doi: 10.1111/jdv.14314. Epub 2017 Jun 6.

PMID:
28485816
42.

Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.

Pérez-Plaza A, Carretero G, Ferrandiz C, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Llamas-Velasco M, Rivera R, Jiménez-Puya R, García-Doval I, Descalzo MA; Biobadaderm Study Group.

J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1021-1028. doi: 10.1111/jdv.14188. Epub 2017 Apr 12.

PMID:
28252811
43.

Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries.

Davila-Seijo P, Garcia-Doval I, Naldi L, Cazzaniga S, Augustin M, Rustenbach SJ, Daudén E, Dam TN, Baker C, Spuls PI, Stern RS, Cohen AD.

Acta Derm Venereol. 2017 Apr 6;97(4):516-518. doi: 10.2340/00015555-2586. No abstract available.

44.

Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis.

Dávila-Seijo P, Dauden E, Carretero G, Ferrandiz C, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Llamas M, Rivera R, Jiménez-Puya R, García-Doval I; BIOBADADERM Study Group.

J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1942-1950. doi: 10.1111/jdv.13682. Epub 2016 Jun 22.

PMID:
27329511
45.

Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis.

Dávila-Seijo P, García-Doval I.

Actas Dermosifiliogr. 2017 Jan - Feb;108(1):3-5. doi: 10.1016/j.ad.2016.09.001. Epub 2016 Oct 17. English, Spanish. No abstract available.

PMID:
27765164
46.

Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti-tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries.

Garcia-Doval I, Cohen AD, Cazzaniga S, Feldhamer I, Addis A, Carretero G, Ferrándiz C, Stern RS, Naldi L; Psonet Network.

J Am Acad Dermatol. 2017 Feb;76(2):299-308.e16. doi: 10.1016/j.jaad.2016.07.039. Epub 2016 Sep 29.

PMID:
27693008
47.

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.

Dávila-Seijo P, Dauden E, Descalzo MA, Carretero G, Carrascosa JM, Vanaclocha F, Gómez-García FJ, De la Cueva-Dobao P, Herrera-Ceballos E, Belinchón I, López-Estebaranz JL, Alsina M, Sánchez-Carazo JL, Ferrán M, Torrado R, Ferrandiz C, Rivera R, Llamas M, Jiménez-Puya R, García-Doval I; BIOBADADERM Study Group.

J Invest Dermatol. 2017 Feb;137(2):313-321. doi: 10.1016/j.jid.2016.08.034. Epub 2016 Sep 25.

48.

Case reports in dermatology: loved by clinicians, loathed by editors, and occasionally important.

Garcia-Doval I, Ingram JR, Naldi L, Anstey A.

Br J Dermatol. 2016 Sep;175(3):449-51. doi: 10.1111/bjd.14869. No abstract available.

PMID:
27632956
49.

Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial.

Gilaberte Y, Robres MP, Frías MP, García-Doval I, Rezusta A, Aspiroz C.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):347-354. doi: 10.1111/jdv.13842. Epub 2016 Aug 12.

PMID:
27515478
50.

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.

García-Doval I, Hernández MV, Vanaclocha F, Sellas A, de la Cueva P, Montero D; BIOBADADERM and BIOBADASER study groups.

Br J Dermatol. 2017 Mar;176(3):643-649. doi: 10.1111/bjd.14776. Epub 2016 Oct 3.

PMID:
27258623

Supplemental Content

Loading ...
Support Center